Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
Recruiting · NCT07493161 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL | Ph+ ALL | Recruiting | Not applicable | 2026-07-23 | NCT07493161 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Blood Diseases Hospital | Tianjin | China | 12 |